Additional file 1 of A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29826151.v1
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 1 of A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease

Figshare
Tuberculosis Research and Epidemiology
article

Additional file 1 of A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease

article en

Abstract

No abstract available for this paper.
Figshare
Shanxi Medical University (CN), Shanghai Jiao Tong University (CN), Peking University (CN), Peking Union Medical College Hospital (CN), First Hospital of Shanxi Medical University (CN), Peking University First Hospital (CN), Sanofi (China) (CN), Children's Hospital of Fudan University (CN), Huazhong University of Science and Technology (CN)
Openalex Percentile: Top 51%
Tuberculosis Research and Epidemiology
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Additional file 1 of A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease · Figshare (2025) | TGRS Research Map | TGRS